There are 2789 resources available
Q&A and live discussion
Presenter: Laurence Albiges
Session: Proffered Paper session - Genitourinary tumours, non-prostate 2
Resources:
Slides
Webcast
Invited Discussant 340O
Presenter: Monika Hegi
Session: Proffered Paper session - CNS tumours
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Monika Hegi
Session: Proffered Paper session - CNS tumours
Resources:
Slides
Webcast
Invited Discussant 341O and 342O
Presenter: Patrick Roth
Session: Proffered Paper session - CNS tumours
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Patrick Roth
Session: Proffered Paper session - CNS tumours
Resources:
Slides
Webcast
Introduction by the chair
Presenter: Omid Hamid
Session: Stay at the bench or move to the bedside: What is the role for neoadjuvant therapy in melanoma today?
Resources:
Slides
Webcast
Yes, ready for primetime in the clinic
Presenter: Paolo Ascierto
Session: Stay at the bench or move to the bedside: What is the role for neoadjuvant therapy in melanoma today?
Resources:
Slides
Webcast
No, appropriate for clinical trial/biomarker work at this time
Presenter: Reinhard Dummer
Session: Stay at the bench or move to the bedside: What is the role for neoadjuvant therapy in melanoma today?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Omid Hamid
Session: Stay at the bench or move to the bedside: What is the role for neoadjuvant therapy in melanoma today?
Resources:
Slides
Webcast
Q&A
Presenter: Omid Hamid
Session: Stay at the bench or move to the bedside: What is the role for neoadjuvant therapy in melanoma today?
Resources:
Slides
Webcast